Liaoning Cheng Da Co., Ltd. (SHA:600739)
11.96
-0.02 (-0.17%)
May 8, 2026, 3:00 PM CST
Liaoning Cheng Da Revenue
Liaoning Cheng Da had revenue of 1.99B CNY in the quarter ending March 31, 2026, a decrease of -22.49%. This brings the company's revenue in the last twelve months to 9.43B, down -12.43% year-over-year. In the year 2025, Liaoning Cheng Da had annual revenue of 9.90B, down -12.29%.
Revenue (ttm)
9.43B
Revenue Growth
-12.43%
P/S Ratio
1.93
Revenue / Employee
2.84M
Employees
3,317
Market Cap
18.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.90B | -1.39B | -12.29% |
| Dec 31, 2024 | 11.29B | 506.45M | 4.70% |
| Dec 31, 2023 | 10.78B | -3.78B | -25.97% |
| Dec 31, 2022 | 14.56B | -3.81B | -20.73% |
| Dec 31, 2021 | 18.37B | 1.43B | 8.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Pharmaceuticals Holding | 288.08B |
| Jointown Pharmaceutical Group | 164.16B |
| C.Q. Pharmaceutical Holding | 82.27B |
| Guangzhou Baiyunshan Pharmaceutical Holdings Company | 78.46B |
| China National Accord Medicines Corporation | 72.95B |
| China National Medicines Corporation | 53.31B |
| China Meheco Group | 35.02B |
| Guangxi LiuYao Group | 20.99B |